3-Aminopperidine-2,6-Dion Hydrochloride CAS 24666-56-6;2686-86-4 Mimọ>99.0% Ile-iṣẹ agbedemeji Lenalidomide
Ruifu Kemikali jẹ olupese ti 3-Aminopperidine-2,6-Dion Hydrochloride (CAS: 24666-56-6; 2686-86-4) pẹlu didara to gaju, agbedemeji ti Pomalidomide (CAS: 19171-19-8).Kemikali Ruifu le pese ifijiṣẹ agbaye, idiyele ifigagbaga, iṣẹ ti o dara julọ, kekere ati awọn iwọn olopobobo ti o wa.Ra 3-Aminoperidine-2,6-Dion Hydrochloride, Please contact: alvin@ruifuchem.com
| Orukọ Kemikali | 3-Aminopperidine-2,6-Dion Hydrochloride |
| Awọn itumọ ọrọ sisọ | 3-Aminopperidine-2,6-Dion HCl;3-Amino-2,6-Piperidinedione Hydrochloride;2,6-Dioxopiperidine-3-Ammonium kiloraidi |
| Nọmba CAS | 24666-56-6 |
| CAS ti o ni ibatan | 2686-86-4;25181-50-4 |
| Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu |
| Ilana molikula | C5H9ClN2O2 |
| Òṣuwọn Molikula | 164.59 |
| Ojuami Iyo | 120 ℃ |
| COA & MSDS | Wa |
| Ipilẹṣẹ | Shanghai, China |
| Brand | Ruifu Kemikali |
| Nkan | Awọn pato |
| Ifarahan | Pa-White Crystalline Powder |
| Mimọ / Analysis Ọna | > 99.0% (HPLC) |
| Ọrinrin (KF) | <0.50% |
| Pipadanu lori Gbigbe | <0.50% |
| Aloku lori Iginisonu | <0.20% |
| Lapapọ Awọn Aimọ | <1.00% |
| Infurarẹẹdi julọ.Oniranran | Ni ibamu si Eto |
| Igbeyewo Standard | Standard Enterprise |
| Lilo | Agbedemeji ti Lenalidomide (CAS: 191732-72-6) |
Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin
3-Aminopperidine-2,6-Dione Hydrochloride (CAS: 24666-56-6; 2686-86-4) jẹ agbedemeji fun igbaradi Lenalidomide (CAS: 191732-72-6).Lenalidomide jẹ iru awọn oogun apakokoro ti o dagbasoke nipasẹ awọn ile-iṣẹ elegbogi ti ẹda ti Amẹrika.O ni ọpọlọpọ awọn iṣẹ bii egboogi-tumor, ilana ajẹsara ati egboogi-angiogenesis.O le dojuti awọn yomijade ti iredodo cytokines, ki o si mu awọn yomijade ti agbeegbe ẹjẹ mononuclear egboogi-iredodo cytokines.O le ṣe idiwọ idagba ti awọn sẹẹli myeloma pupọ ti awọn alaisan ati sẹẹli MM1S.Awọn iwadii ile-iwosan ti iṣakoso afọju afọju meji-meji multicenter ṣe iṣiro aabo ati ipa imularada ti lenalidomide ti a lo fun ọpọ myeloma.Awọn abajade iwadii ile-iwosan aipẹ fihan pe lenalidomide ko ni ipa alumoni nikan lori atọju MDS ati MM, ṣugbọn tun lori atọju myeloma, lukimia, carcinoma kidirin metastatic, tumor ti o lagbara, amyloidosis ti idiopathic ti a ṣakopọ ati arun fibrosis ọra inu eegun pẹlu ọra inu ọra.Ni Oṣu Kejila ọdun 2005, Ile-iṣẹ Ounje ati Oògùn AMẸRIKA (FDA) fọwọsi lenalidomide lati ṣee lo ninu itọju ailera mielodysplastic (MDS).
